Dupilumab

Dupilumab, sold under the brand name Dupixent, is a monoclonal antibody blocking interleukin 4 and interleukin 13, used for allergic diseases such as eczema (atopic dermatitis), asthma and nasal polyps which result in chronic sinusitis.[3][4][5][1] Side effects include decreased levels of T helper cells, cold sores, allergic reactions and inflammation of the cornea.[4] It was developed by Regeneron Pharmaceuticals... [wikipedia]